Treamid, also known as bisamide derivative of dicarboxylic acid (BDDA), is a complexing agent that has been found to chelate metal ions, including calcium, copper, iron, magnesium, and zinc. This... This drug has shown regenerative properties and restoration of the function of various tissues and organs.
- Mechanism
- Curator reviewed · 1 reference
In animal studies, treamid displays a positive effect on the capillaries of lungs, exhibits anti-fibrotic activity, and increases the number of endothelial progenitor cells in the lungs of animals with pulmonary fibrosis. Currently, the drug is being investigated against COVID-19.
- Also known as
- BDDA · Bisamide derivative of dicarboxylic acid
- Code names
- XC268BG
Resolves to
What you can answer from here — as of December 20, 2020
Which companies are running trials of Treamid, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account